"The child is big should let go" song zhiping five years of gains and losses

On the evening of April 16, the 21st century Economic report was exclusively informed of the substitution of the chairman of the China Pharmaceutical Group Corporation, under the Deputy Secretary-General Guo Jianxin as the new chairman, the original Chairman song Zhiping today. Earlier, song zhiping Body and China Building materials group and China Pharmaceutical Group Corporation chairman of the two central enterprises, is the only one of the chairman of the double. The sudden departure of one of them at this time inevitably leads to speculation. In the song Zhiping to the news, song smiled to the 21st century economic reporter said that the main reason is the two-term, department recently issued a new regulation of part-time. "The child is big, should let go", so the song to SASAC application expired. "The child is big should let go" 21st century: What is the reason why you stepped down as chairman of the group? Song zhiping: I officially stepped down yesterday (April 15), in fact, my term in the medicines is to achieve the official expiry of last October, I have repeatedly put forward to SASAC, after the expiration of the next chairman is no longer, any two period on it, did four years, the expiration of the retirement is also a successful outcome. In the past five years, the development of the medicines has been very good and has undergone profound changes. The formation of the Central Enterprise of medicine and health platform, into the world's top 500, the construction of the national pharmaceutical Network, while in the scientific research in the industry has also made breakthrough progress, in the reform of the Board's work, SASAC is also very satisfied with the SASAC is running a good board. In the process of market-oriented reform, it should be said that a number of steps have been taken, at this moment, the medicines have a clear strategy, embarked on a benign development of the road, it has been on a high platform for development, so I also to leave the time. "21st century": You mean in the past five years, you have paved the road, then the Chinese medicines can be developed? Song zhiping: Yes, the child is big and should let go. Business is the children of entrepreneurs, it is not easy to cultivate children, but as entrepreneurs, sometimes have to choose to leave, so that good people to continue the cause. I think the current of the medicines, I am very satisfied with the second is very reassuring, this time is also the time to leave. Board trial still flawed "21st century": the Sasac sent you to be the chairman of the President, what did you ask? What kind of goal would you like to achieve? Song zhiping: There are a few goals, one is to build the central enterprises of the medical health platform, this is SASAC's urgent need to do at the time, was once to the China resources to build this platform, then Sasac has a great strategic change, hoping to create a separate health platform for medicine, so, I went to the purpose is to build this platform. The second task is reorganization. China Health Group, Shanghai Medical Engineering Institute, and out of the service are all central enterprises, my task is to be sure to go to the several companies voluntarily combined. Perhaps I used to have a successful reorganization of building materials experience, so SASAC let me do the work of the four-enterprise unity. "21st century": What about your self-assessment of the completion of the mission? Song zhiping: I think all these tasks are done. Of course, SASAC also hope that in the manufacturing industry, in research and development, including Chinese medicine can make achievementsTo。 It should be said that in recent years we have a great breakthrough in Chinese medicine, the acquisition of a listed company in Hong Kong, in the domestic acquisition of Tongji Hall, done very well. The development of modern medicines is irresistible. We have a very good research and development platform, such as the China Institute of Pharmaceutical Industry. The manufacturing platform also has, one is the Chinese biology, does the biological pharmacy, also has one Chinese traditional medicine, is makes the Chinese medicine, but also has a medical equipment. In addition, we have recently entered the hospital to build two new hospitals to try to reform the public hospitals. After the intervention of the hospital also began to do the Sunshine Medical examination, next to the medicine also want to do the cause of endowment. "21st century": Is it so broad that the whole industry chain is to be done? Song zhiping: In fact, can not call the whole industry chain, can only be called limited correlation. The core industry is medical and pharmaceutical, and then expands to do it around the industry. "21st century": Sasac initially let you to become the external chairman of the group, but also to engage in the intention of the Board pilot, I do not know in the past few years, the Board of the results of the pilot work? Song zhiping: I personally feel that Sasac's board of directors pilot, overall is successful. Because the board's pilot captures a central issue, that is, the external directors are the majority, and the outside directors are the convenor of the special committees under the Board of Directors, thus settling the board's affairs. Before the board a gang of two brands, the insider to do it, now is really the decision-making level and executive layer separate, this part of the SASAC pilot very successful. The lack of a board trial is that our cadre management system still needs to be reformed, and the personnel rights of the Board of directors need to be given. At the moment the board's powers are very decentralized in project decisions, but they have not been dropped on personnel management, such as the appointment of managers to the board. However, it is said that Sasac is currently studying the possibility of August will be the plan, the board of directors to hire management. Another, I think the next board will also increase its independence. Around the separation of enterprises and enterprises, with the SASAC to the management of capital-oriented transformation, as easy, director of SASAC, said that the Commission should not be a matter of mind, can not ignore the matter, but also let enterprises to do, despite their own should be the matter, then the board will face more responsibility, but also have more rights. You know, in fact, the board is the company's decision-making body, is not a simple checks and balances, it is responsible for the development and performance of the company, management is only its principal agency, so the general manager and management of the matter should be the board of directors, not to the general manager to be responsible. Moreover, the directors should be legally responsible for the company and unlimited liability, which requires us to raise the company's board to a higher level, to increase its independence, this is also the future we have to deeply understand and in the reform to do.